Hims & Hers Health Inc
(NYSE:HIMS)
$6.29
-0.07[-1.10%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$6.29
0[0.00%]
Open6.420Close6.290
Vol / Avg.2.028M / 2.833MMkt Cap1.327B
Day Range6.240 - 6.54052 Wk Range4.015 - 12.340

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Hims & Hers Health Stock (NYSE:HIMS), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$18.00

Lowest Price Target1

$6.00

Consensus Price Target1

$10.13

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
81600

Analyst Firms Making Recommendations1

  • Truist Securities
  • Credit Suisse
  • TD Cowen
  • Piper Sandler
  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Hims & Hers Health

All Ratings (38)

Upgrades (6)

Downgrades (1)

Initiations (11)

Q

What is the target price for Hims & Hers Health (HIMS)?

A

The latest price target for Hims & Hers Health (NYSE: HIMS) was reported by Truist Securities on August 9, 2023. The analyst firm set a price target for $10.00 expecting HIMS to rise to within 12 months (a possible 58.98% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hims & Hers Health (HIMS)?

A

The latest analyst rating for Hims & Hers Health (NYSE: HIMS) was provided by Truist Securities, and Hims & Hers Health maintained their hold rating.

Q

When is the next analyst rating going to be posted or updated for Hims & Hers Health (HIMS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.

Q

Is the Analyst Rating Hims & Hers Health (HIMS) correct?

A

While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $12.00 to $10.00. The current price Hims & Hers Health (HIMS) is trading at is $6.29, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.